Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koc-Kan Ho

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Small molecule biaryl FSH receptor agonists. Part 2: Lead optimization via parallel synthesisTao Guo, Anton E P Adang, Guizhen Dong, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonistsJeffrey J Letourneau, Christopher M Riviello, Hong Li, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Small molecule biaryl FSH receptor agonists. Part 1: Lead discovery via encoded combinatorial synthesisTao Guo, Anton E P Adang, Roland E Dolle, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 5, 2009
Nonpeptidergic allosteric antagonists differentially bind to the CXCR2 chemokine receptorPetra de Kruijf, Jane van Heteren, Herman D Lim, et al.
Molecular Cancer Therapeutics|May 31, 2013
Pharmacologic activation of PKM2 slows lung tumor xenograft growthK Mark Parnell, Jason M Foulks, Rebecca N Nix, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2010
Discovery of novel quinolinone adenosine A2B antagonistsBrian F McGuinness, Koc-Kan Ho, Tara M Stauffer, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2009
Triazine and pyrimidine based ROCK inhibitors with efficacy in spontaneous hypertensive rat modelKoc-Kan Ho, James R Beasley, Laura Belanger, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2011
Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2006
Imidazolylpyrimidine based CXCR2 chemokine receptor antagonistsKoc-Kan Ho, Douglas S Auld, Adolph C Bohnstedt, et al.
Neoplasia (New York, N.Y.)|June 24, 2014
A small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomasJason M Foulks, Kent J Carpenter, Bai Luo, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Small molecule biaryl FSH receptor agonists. Part 2: Lead optimization via parallel synthesisTao Guo, Anton E P Adang, Guizhen Dong, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonistsJeffrey J Letourneau, Christopher M Riviello, Hong Li, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Small molecule biaryl FSH receptor agonists. Part 1: Lead discovery via encoded combinatorial synthesisTao Guo, Anton E P Adang, Roland E Dolle, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 5, 2009
Nonpeptidergic allosteric antagonists differentially bind to the CXCR2 chemokine receptorPetra de Kruijf, Jane van Heteren, Herman D Lim, et al.
Molecular Cancer Therapeutics|May 31, 2013
Pharmacologic activation of PKM2 slows lung tumor xenograft growthK Mark Parnell, Jason M Foulks, Rebecca N Nix, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2010
Discovery of novel quinolinone adenosine A2B antagonistsBrian F McGuinness, Koc-Kan Ho, Tara M Stauffer, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2009
Triazine and pyrimidine based ROCK inhibitors with efficacy in spontaneous hypertensive rat modelKoc-Kan Ho, James R Beasley, Laura Belanger, et al.
Bioorganic & Medicinal Chemistry Letters|May 21, 2011
Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonistsSusan E Napier, Jeffrey J Letourneau, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2006
Imidazolylpyrimidine based CXCR2 chemokine receptor antagonistsKoc-Kan Ho, Douglas S Auld, Adolph C Bohnstedt, et al.
Neoplasia (New York, N.Y.)|June 24, 2014
A small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomasJason M Foulks, Kent J Carpenter, Bai Luo, et al.
Pageof 3